Skip to main content

A California jury on Wednesday cleared Johnson & Johnson of liability in a case involving a woman who alleged that the company’s talc-based products, including its baby powder, contain asbestos and caused her cancer, the company said.

The jury in Humboldt County Superior Court in Eureka, California rejected claims by Carla Allen who said that her mesothelioma, a tissue cancer closely linked to asbestos exposure, was caused by the company’s talc products, including Johnson’s Baby Powder.

J&J denies the allegations, saying decades of scientific testing and regulatory approvals have shown its talc to be safe and asbestos-free.

Story continues below advertisement

Plaintiffs in the litigation allege that J&J knew of asbestos fibres in its cosmetic talc and concealed risks associated with the products.

The New Brunswick, New Jersey-based company faces some 11,700 U.S. talc lawsuits, according to an October regulatory filing. More than 9,700 of those cases involve claims over ovarian cancer, recent filings in New Jersey federal court, where most of the cases are consolidated, showed.

The remaining plaintiffs allege asbestos in J&J’s talc caused them to develop mesothelioma.

J&J in a statement on Wednesday said it was pleased with the jury’s decision in the case of Allen.

“While we deeply sympathize with anyone suffering from any form of cancer, the science and facts show that her disease was not caused by her use of our talcum-based products,” the company said.

The California jury reached its decision following a roughly seven-week long jury trial, court records showed, but further details were not immediately available.

Lawyers for Allen did not immediately respond to a request for comment.

Story continues below advertisement

J&J has been fighting talc cancer lawsuits for several years, but the litigation shifted in recent months to include allegations of asbestos contamination.

Plaintiffs now claim asbestos fibres in the products are causing both ovarian cancer and mesothelioma.

J&J to date has been cleared of liability in three mesothelioma cases. It has lost two mesothelioma cases in New Jersey and California, with juries awarding a total of $142-million in damages. Both cases are under appeal.

Four additional mesothelioma cases resulted in a mistrial because jurors could not reach a verdict or because the plaintiff died.

In July, a Missouri jury hit J&J with a massive $4.69-billion verdict in the first trial alleging asbestos contamination has caused ovarian cancer in 22 women. That decision is also under appeal.

Report an error
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter